Wuxi Biologics (Cayman) Inc. KKPS DR (WUXI06) Hisse Senedi Fiyatı ve Haberler

WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia

Wuxi Biologics (Cayman) Inc. KKPS DR hakkında

CEOZhisheng Chen

Çalışan Sayısı14,7 B

Kuruluş Tarihi2010

Genel Merkez-

Sektör-

Web Sitesiwuxibiologics.com

Tüm değerler CNY birimindedir	Eyl 2025	Ara 2025	Mar 2026	Haz 2026
Gelir	5,92 Mr	5,92 Mr	5,89 Mr	5,89 Mr
Satılan malların maliyeti	3,04 Mr	3,04 Mr	3,17 Mr	3,17 Mr
Gelirin maliyeti	3,04 Mr	3,04 Mr	3,17 Mr	3,17 Mr
Araştırma ve geliştirme giderleri	254,93 Mn	254,93 Mn	215,11 Mn	215,11 Mn
Araştırma ve geliştirme giderleri toplamı	-	-	-	-
Satış, genel ve yönetim giderleri	631,03 Mn	631,03 Mn	591,61 Mn	591,61 Mn
İşletme gideri	921,71 Mn	921,71 Mn	860,09 Mn	860,09 Mn
Toplam işletme giderleri	3,96 Mr	3,96 Mr	4,03 Mr	4,03 Mr
Faaliyet geliri	1,96 Mr	1,96 Mr	1,86 Mr	1,86 Mr
Diğer faaliyet dışı gelirler	33,58 Mn	33,58 Mn	42,20 Mn	42,20 Mn
Olağan dışı kalemler dahil vergi öncesi kâr	1,96 Mr	1,96 Mr	1,71 Mr	1,71 Mr
Olağan dışı kalemler hariç vergi öncesi kâr	1,94 Mr	1,94 Mr	1,70 Mr	1,70 Mr
Gelir vergisi gideri	476,10 Mn	476,10 Mn	251,54 Mn	251,54 Mn
Fiilî vergi oranı	%24,24	%24,24	%14,71	%14,71
Diğer işletme giderleri	-	-	-	-
Net gelir	1,28 Mr	1,28 Mr	1,22 Mr	1,22 Mr
Net kâr marjı	%21,70	%21,70	%20,70	%20,70
Hisse başına kazançlar	-	-	-	-
Faiz ve yatırım geliri	115,29 Mn	115,29 Mn	106,38 Mn	106,38 Mn
Faiz masrafı	-29,76 Mn	-29,76 Mn	-22,28 Mn	-22,28 Mn
Net faiz giderleri	85,53 Mn	85,53 Mn	84,10 Mn	84,10 Mn
Amortisman ve itfa giderleri	-	-	-	-
EBITD (Faiz, Vergi, Amortisman, Aşınma Payı Öncesi Kazançlar)	2,24 Mr	2,24 Mr	2,27 Mr	2,27 Mr
Varlık satışı kaynaklı kâr veya zarar	317,34 Mn	317,34 Mn	-	-

Finans

Soru sorun